On Monday, CLSA analyst Indrajit Agarwal adjusted the price target for JSW Steel Ltd (NSE:JSTL:IN), reducing it to INR780.00 from the previous INR820.00 while maintaining an Underperform rating on ...

Global brokerage firm CLSA has released its 2025 outlook for India's healthcare sector, projecting an 8-9 percent growth in the Indian pharmaceutical market, slightly outpacing the anticipated ...

Amid calls for higher capex push, CLSA says that the government will stick to its commitment of a 4.9% fiscal deficit in fiscal 2025 and 4.5% next year. This fiscal deficit commitment will require the ...

Despite weak Q3 earnings, Bharat Petroleum (BPCL) draws attention from global brokerages. CLSA upgraded BPCL to ‘Hold’ with a target of Rs 270, while Morgan Stanley maintains an ‘Overweight’ rating ...

Healthcare stocks see mixed performance as Dr Lal Pathlabs and Aurobindo Pharma rise over 2% after CLSA upgrades their ratings to 'outperform.' Dr Reddy's Laboratories falls 1% after a downgrade to ...

You need to be a subscriber to view this content.

To increase the sector's efficiency, it also suggested putting the 2021 report on the agricultural value chain into practice.